PHF6 and acute myeloid leukemia: AML patients with high PHF6 expression had unfavorable prognosis than AML patients with low PHF6 expression (p = 0.0329) according to the survival time of patients with more than one year from the Cancer Genome Atlas AML dataset (Supplementary Fig. 1A).